✦ LIBER ✦

Failure of anti-EGFR therapy in p16-positive head and neck cancer – Authors' reply

✍ Scribed by Vermorken, Jan B; Bach, Bruce A

Book ID: 123446482
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 48 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(13)70289-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Failure of anti-EGFR therapy in p16-posi

Failure of anti-EGFR therapy in p16-positive head and neck cancer

✍ Roesler, Rafael; Schwartsmann, Gilberto 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 50 KB

Anti-EGFR therapy in head and neck cance

Anti-EGFR therapy in head and neck cancer: A surgeon's perspective

✍ Colin Liew; C. Lemon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Anti-EGFR monoclonal antibody promising

Anti-EGFR monoclonal antibody promising in head and neck cancer

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Anti-EGFR monoclonal antibody beneficial

Anti-EGFR monoclonal antibody beneficial in head and neck cancer

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Perspectives of combined radioimmunother

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer

✍ Frank B. van Gog; Ruud H. Brakenhoff; Marijke Stigter-van Walsum; Gordon B. Snow 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 119 KB 👁 2 views

Rhenium-186 based radioimmunotherapy (RIT) may have potential for the treatment of minimal residual disease in patients with squamous cell carcinoma of head and neck (HNSCC). In an effort to enhance the efficacy of RIT, we evaluated the combination of RIT and anti-epidermal growth factor receptor (E

Causes of failure in the radiation thera

Causes of failure in the radiation therapy of head and neck cancer

✍ Lester J. Peters; Gilbert H. Fletcher 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 101 KB